Fast-progressing HIV Strain Discovered in Cuba

A newly discovered fast-progressing strain of HIV discovered in Cuba has been found to lead to AIDS as much as three times faster than the most common strains of the virus, a study by the University of Leuven in Belgium has shown.

To investigate the potentially increased proportion of Cuban patients with rapid progression to AIDS over the past decade - mostly white males from Havana in their early 30s - the research team set up an exploratory study evaluating the association of rapid progression with epidemiological, clinical, viral and immunological parameters, comparing three groups of patients.

The first two groups were newly diagnosed patients who had had an HIV negative test less than three years earlier. They either had been already diagnosed with AIDS (AIDS-RP) or were still AIDS-free (non-AIDS). The third group were chronically infected HIV-1 patients with AIDS.

All of the patients infected with CRF19, a recombinant of subtype D, subtype A and subtype G, with a subtype D protease, were found to have higher loads of the virus in their bodies. They were also more likely to have developed AIDS within three years, the study published in the journal EBioMedicine noted.

The findings led the researchers to conclude that an evolutionary very fit CRF19 together with co-infections is behind the increase of rapid progression to AIDS.

Free Virtual Event

ProteiNext 2025

ProteiNext 2025

ProteiNext is an annual symposium that offers a platform for sharing insights on protein analysis

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.

Photo
08.11.2024 • News

Future Prospects in Green Chemistry

The Discourse on Green Chemistry Interactive Pitch Competition, held on November 5, 2024, at Wiley's Berlin office as part of Berlin Science Week, showcased a range of innovative projects aimed at addressing critical environmental challenges.